USA TODAY covers the copycat GLP-1 crackdown, from the Apothecary Pharma recall to an import alert on a Chengdu factory. Novo says it has filed over 130 lawsuits.
Recap by typeshit. Full story at Yahoo.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
A fitness coach says clients on GLP-1 drugs often focus on how fast weight drops instead of whether they eat enough protein.
She points to women getting pregnant unexpectedly after GLP-1s restore ovulation, and questions the mixed messages women get about these drugs and fertility.
Access to Ozempic, Wegovy and Mounjaro in Australia often comes down to who can pay, raising the question of public subsidies.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
Loading…